Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Costa

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
European Journal of Internal Medicine|May 9, 2020
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injuryLucia De Franceschi, Enrico Costa, Francesco Dima, et al.
Recenti Progressi in Medicina|July 19, 2022
[Access to medicines for rare diseases: regulatory aspects and public health priorities.]Enrico Costa, Gianluca Grimaldi, Vittorio Del Grosso, et al.
Orphanet Journal of Rare Diseases|May 7, 2022
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosisEnrico Costa, Silvia Girotti, Francesca Pauro, et al.
Internal and Emergency Medicine|October 23, 2020
Can oral formulation increase the risk of lormetazepam abuse?Enrico Costa, Enrico Sterzi, Federico Tedeschi, et al.
Current Opinion in Allergy and Clinical Immunology|September 27, 2022
Trends and determinants of epinephrine prescriptions: a proxy of anaphylaxis epidemiology?Enrico Costa, Luciana Kase Tanno, Damiano Salazzari, et al.
Plos One|October 13, 2022
Promoting engagement with quality communication in social mediaMatteo Cinelli, Antonio Peruzzi, Ana Lucía Schmidt, et al.
American Journal of Hematology|November 12, 2024
Globalization in clinical drug development for sickle cell diseaseEnrico Costa, Russell E Ware, Léon Tshilolo, et al.
British Journal of Clinical Pharmacology|January 10, 2025
Performance of the accelerated assessment of the European Medicines AgencyVittorio Del Grosso, Martina Perini, Giorgio Casilli, et al.
American Journal of Hematology|September 25, 2020
Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable costEnrico Costa, Prosper Tibalinda, Enrico Sterzi, et al.
Le Infezioni in Medicina|June 24, 2014
[Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital]Enrico Costa, Valeria Biasi, Ercole Concia, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Internal Medicine|May 9, 2020
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injuryLucia De Franceschi, Enrico Costa, Francesco Dima, et al.
Recenti Progressi in Medicina|July 19, 2022
[Access to medicines for rare diseases: regulatory aspects and public health priorities.]Enrico Costa, Gianluca Grimaldi, Vittorio Del Grosso, et al.
Orphanet Journal of Rare Diseases|May 7, 2022
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosisEnrico Costa, Silvia Girotti, Francesca Pauro, et al.
Internal and Emergency Medicine|October 23, 2020
Can oral formulation increase the risk of lormetazepam abuse?Enrico Costa, Enrico Sterzi, Federico Tedeschi, et al.
Current Opinion in Allergy and Clinical Immunology|September 27, 2022
Trends and determinants of epinephrine prescriptions: a proxy of anaphylaxis epidemiology?Enrico Costa, Luciana Kase Tanno, Damiano Salazzari, et al.
Plos One|October 13, 2022
Promoting engagement with quality communication in social mediaMatteo Cinelli, Antonio Peruzzi, Ana Lucía Schmidt, et al.
American Journal of Hematology|November 12, 2024
Globalization in clinical drug development for sickle cell diseaseEnrico Costa, Russell E Ware, Léon Tshilolo, et al.
British Journal of Clinical Pharmacology|January 10, 2025
Performance of the accelerated assessment of the European Medicines AgencyVittorio Del Grosso, Martina Perini, Giorgio Casilli, et al.
American Journal of Hematology|September 25, 2020
Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable costEnrico Costa, Prosper Tibalinda, Enrico Sterzi, et al.
Le Infezioni in Medicina|June 24, 2014
[Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital]Enrico Costa, Valeria Biasi, Ercole Concia, et al.
Pageof 4